Skip to main content

Table 1 Characteristics of the participants

From: Transcutaneous electrical acupoint stimulation improves endometrial receptivity resulting in improved IVF-ET pregnancy outcomes in older women: a multicenter, randomized, controlled clinical trial

Characteristics

TEAS group (n = 362)

Control group (n = 369)

P

Age, years (mean ± SD)

31.5 ± 4.4

31.7 ± 4.7

0.749

Race, n (%)

  

0.317

  Han

345 (95.3)

357 (96.8)

 

  Minorities

17 (4.7)

12 (3.3)

 

BMI, kg/m2 (mean ± SD)

22.5 ± 3.0

22.4 ± 3.1

0.556

Drinking history, n (%)

360 (99.5)

368 (99.7)

0.621

Years of infertility (years)

3 (2,6)

4 (2,6)

0.579

History of acupuncture, n (%)

15 (4.1)

10 (2.7)

0.289

Times of IVF-ET, n (%)

  

0.423

  1

185 (51.1)

196 (53.1)

 

  2–3

175 (48.3)

168 (45.5)

 

  ≥ 4

2 (0.6)

5 (1.4)

 

Causes of infertility, n (%)

  

0.824

  Gamete transport disorders

333 (92.0)

341 (92.4)

 

  Ovulation dysfunction

18 (5.0)

14 (3.8)

 

  Endometriosis

6 (1.7)

8 (2.2)

 

  Immunological infertility

5 (1.4)

6 (1.6)

 

Embryo, n (%)

  

0.771

  Fresh

183 (50.6)

190 (51.6)

 

  Cryopreserved

179 (49.5)

178 (48.4)

 

Comorbidities (before treatment), n (%)

  

0.953

  Hyperlipemia

2 (0.6)

0

 

  Hyperprolactinemia

2 (0.6)

3 (0.8)

 

  Hyperthyroidism

1 (0.3)

1 (0.3)

 

  Subhypothyroidism

2 (0.6)

2 (0.5)

 

  Hypothyroidism

3 (0.8)

1 (0.3)

 

Uterine cavity lesions, n (%)

  

0.833

  Submucous myoma

8 (2.2)

11 (3.0)

 

  Uterine mediastinum

2 (0.6)

0

 

Thin endometrium due to repeated curettages

1 (0.3)

3 (0.8)

 

Drugs, n (%)

  Combined drug therapy after inclusion

122 (33.7)

125 (33.9)

0.938

  Continue drug therapy after inclusion

24 (6.6)

34 (9.2)

0.219

  1. TEAS transcutaneous electrical acupoint stimulation, BMI body mass index, IVF-ET in vitro fertilization-embryo transfer